-
EP1585985
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1585985
| EP1585985 - HUMAN PELLINO POLYPEPTIDES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.10.2010 Database last updated on 18.10.2024 | Most recent event Tooltip | 01.10.2010 | Application deemed to be withdrawn | published on 03.11.2010 [2010/44] | Applicant(s) | For all designated states Immunex Corporation Law Department, 51 University Street Seattle, WA 98101 / US | For all designated states THE CLEVELAND CLINIC FOUNDATION 9500 Euclid Avenue Cleveland, OH 44195 / US | [N/P] |
| Former [2005/42] | For all designated states IMMUNEX CORPORATION Law Department, 51 University Street Seattle, WA 98101 / US | ||
| For all designated states THE CLEVELAND CLINIC FOUNDATION 9500 Euclid Avenue Cleveland, OH 44195 / US | Inventor(s) | 01 /
BIRD, Timothy, A 10804 Olallie Drive NE Bainbridge Island, WA 98110 / US | 02 /
COSMAN, David, J. 9808 Mandus Olson Road NE Bainbridge Island, WA 98110 / US | 03 /
LI, Xiaoxia 9500 Euclid Avenue Cleveland, OH 44195 / US | [2005/42] | Representative(s) | Dörries, Hans Ulrich df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | [N/P] |
| Former [2005/42] | Dörries, Hans Ulrich Dörries, Frank-Molnia & Pohlman, Triftstrasse 13 80538 München / DE | Application number, filing date | 03812915.1 | 09.12.2003 | [2005/42] | WO2003US39188 | Priority number, date | US20020317250 | 11.12.2002 Original published format: US 317250 | [2005/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004053092 | Date: | 24.06.2004 | Language: | EN | [2004/26] | Type: | A2 Application without search report | No.: | EP1585985 | Date: | 19.10.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.06.2004 takes the place of the publication of the European patent application. | [2005/42] | Search report(s) | International search report - published on: | US | 10.09.2004 | (Supplementary) European search report - dispatched on: | EP | 05.01.2006 | Classification | IPC: | C07K14/52, G01N33/53, C12Q1/68 | [2006/06] | CPC: |
C07K14/47 (EP,US);
A61P29/00 (EP);
C07K14/4705 (EP,US);
C07K2319/00 (EP,US)
|
| Former IPC [2005/42] | G01N33/53, C12Q1/68, C07K14/52 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/42] | Extension states | AL | 05.07.2005 | LT | 05.07.2005 | LV | 05.07.2005 | MK | 05.07.2005 | Title | German: | HUMANE PELLINOPOLYPEPTIDE | [2005/42] | English: | HUMAN PELLINO POLYPEPTIDES | [2005/42] | French: | POLYPEPTIDES PELLINO HUMAINS | [2005/42] | Entry into regional phase | 05.07.2005 | National basic fee paid | 05.07.2005 | Search fee paid | 05.07.2005 | Designation fee(s) paid | 05.07.2005 | Examination fee paid | Examination procedure | 05.07.2005 | Examination requested [2005/42] | 18.04.2006 | Despatch of a communication from the examining division (Time limit: M04) | 14.08.2006 | Reply to a communication from the examining division | 30.12.2009 | Despatch of a communication from the examining division (Time limit: M04) | 11.05.2010 | Application deemed to be withdrawn, date of legal effect [2010/44] | 11.06.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/44] | Fees paid | Renewal fee | 15.12.2005 | Renewal fee patent year 03 | 13.12.2006 | Renewal fee patent year 04 | 12.12.2007 | Renewal fee patent year 05 | 31.03.2008 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.12.2009 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [PX]WO03100000 (TULARIK INC [US], et al) [PX] 8-21* page 126 - page 128; examples XIII,XV *; | [X] - YU KANG-YEOL ET AL, "Cutting edge: mouse pellino-2 modulates IL-1 and lipopolysaccharide signaling.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 OCT 2002, (20021015), vol. 169, no. 8, ISSN 0022-1767, pages 4075 - 4078, XP002358356 [X] 8-10,16 * page 4076 - page 4077; figure 3 * | International search | [Y]WO0183739 (IMMUNEX CORP [US], et al); | [Y] - LI ET AL, "IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase", PNAS USA, (20020416), vol. 99, no. 8, pages 5567 - 5572, XP002268506 DOI: http://dx.doi.org/10.1073/pnas.082100399 | [YP] - JIANG ET AL, "Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex", J. BIOL. CHEM., (20030328), vol. 278, no. 13, pages 10952 - 10956, XP002978492 DOI: http://dx.doi.org/10.1074/jbc.M212112200 |